Pharmaceutical Excipients Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Pharmaceutical Excipients Market Share and it is Segmented by Product Type (Inorganic Chemicals, Organic Chemicals, and Other Products), Functionality (Fillers and Diluents, Binders, Suspension, and Viscosity Agents, Coatings, Flavoring Agents, Disintegrants, Colorants, Preservatives, and Other Functionalities), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market size and forecasts are provided in terms of value (USD) for all the above segments.

Pharmaceutical Excipients Market Size

Single User License
Team License
Corporate License
Book before:
Pharmaceutical Excipients Market Summary
share button
Study Period 2019 - 2029
Market Size (2024) USD 9.94 Billion
Market Size (2029) USD 14.56 Billion
CAGR (2024 - 2029) 7.93 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Pharmaceutical Excipients Market

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

Pharmaceutical Excipients Market Analysis

The Pharmaceutical Excipients Market size is estimated at USD 9.94 billion in 2024, and is expected to reach USD 14.56 billion by 2029, growing at a CAGR of 7.93% during the forecast period (2024-2029).

The COVID-19 pandemic had a significant impact on the pharmaceutical industry. Initially, pharmaceutical excipient companies faced substantial challenges, such as a low supply of medical items and a strict lockdown imposed by the government worldwide that impacted the global supply chain of raw materials from manufacturing hubs such as India and China.

However, the increased focus on developing therapeutics for COVID-19 significantly impacted the market growth. For instance, in February 2021, Evonik signed a strategic partnership with BioNTech on the COVID-19 vaccine. Evonik also planned to invest in the short-term expansion of its specialty lipid production, an excipient essentially required to develop mRNA-based COVID-19 vaccines. Thus, Evonik made an important contribution to the Pfizer BioNTech COVID-19 vaccine by supplying lipid excipients to speed up the COVID-19 vaccine development process. The COVID-19 pandemic initially had a positive impact on the market; however, as the pandemic has subsided, the market has lost some traction, and thus the market is expected to grow steadily during the forecast period.

The major factors responsible for the growth of the pharmaceutical excipients market include the increasing demand for functional excipients, recent patent expiries driving the need for pharmaceutical excipients, and rapid advancements in nanotechnology.

The growing pharmaceutical industry and increasing pharmaceutical production also propel the market's growth. For instance, according to the European Federation of Pharmaceutical Industries and Associations, 2022 report, the production of pharmaceuticals in the European region increased by 4.6% to EUR 300,000 million in 2021. Thus, such an increase in production value corresponds to an increase in the volume of production of pharmaceuticals, in turn boosting the demand for pharmaceutical excipients.

Furthermore, the expansion of facilities by the market players to develop high-performance ingredients is also expected to propel the market's growth. For instance, in July 2021, Croda International Plc opened a new high-purity excipients facility in Mill Hall, London. The investment led to Croda's commitment to developing innovative pharmaceutical excipients for use in smart science. Moreover, the increase in the launch of new products also contributes to the market's growth. For instance, in July 2021, DFE Pharma launched a new addition to its broad excipient portfolio, Pharmacel sMCC 90. It is silicified microcrystalline cellulose (MCC).

Thus, the market is expected to project growth over the forecast period due to the abovementioned factors. However, the lack of a proper approval process, adverse reactions of excipients, and contamination in formulations may hinder the market's growth.

Pharmaceutical Excipients Market Trends

Binders Segment is Expected to Show a Significant Growth Over the Forecast Period

Binder excipients are formulated to act as an adhesive to bind together granules, powders, and other dry ingredients to provide mechanical strength to the finished dosage form. Binders such as starch, gelatin, polyvinylpyrrolidone (PVD), and hydroxypropyl methylcellulose (HPMC) also provide the desired shape to capsules or tablets and prevent the separation of active pharmaceutical ingredients from other excipients such as fillers, lubricants, disintegrants, among others.

The binders segment is expected to project significant growth over the forecast period owing to increasing demand for pharmaceutical and biopharmaceutical drugs, advancements in drug delivery technologies such as multi-particulate systems, controlled-release dosage forms, and the active participation of prominent players in the launch of high-quality binders.

The pharmaceutical industry has gradually recognized binders to be able to assist active pharmaceutical ingredients in achieving better functionality and providing a competitive advantage. Additionally, with the increase in the production of pharmaceuticals, the requirement for binders is also expected to increase, propelling the segment's growth. For instance, according to the India Brand Equity Foundation (IBEF) 2022 report, globally, India ranked third for pharmaceutical production by volume and 14th by value in 2022. Therefore, India's strong position in the pharmaceutical industry by volume and value is projected to drive the segment's growth by increasing demand for binder and offering binders at competitive prices, making them an attractive option for global pharmaceutical companies.

In addition, the launch of technologically advanced and innovative products is propelling the growth of the market segment. For instance, in October 2021, Beneo launched galenIQ 721. It is a filler binder that improves the taste and stability of effervescent tablets and powders. It is a non-hygroscopic, water-soluble, and directly compressible excipient and thus offers high-content uniformity and production efficiency for effervescent applications. Moreover, the strategic initiatives taken by the market players also contribute to the growth of the market segment. For instance, in January 2022, DFE Pharma expanded its nutraceutical portfolio with the launch of three starch-based excipients, namely Nutroféli ST100 (native starch), Nutroféli ST200 (partially pregelatinized starch), and Nutroféli ST300 (completely gelatinized starch). These are naturally sourced, multifunctional excipients that can be used as binders, fillers, and other applications for oral solid dosage forms and conform to food and pharma monographs.

Thus, the market segment is expected to show significant growth over the forecast period due to the abovementioned factors.

image

North America is Expected to Witness Significant Market Share over the Forecast Period

North America holds a significant share in the pharmaceutical excipients market and is expected to follow a similar trend over the forecast period. Factors such as the fast-growing pharmaceutical industry, increasing demand for functional excipients, the presence of major players in the region, and advancements in technology will majorly drive the growth of the market over the forecast period.

Launching technologically advanced or superior excipients also propels the market's growth. For instance, in May 2022, Lubrizol Life Science (LLS) Health, one of the global leaders in accelerating success and innovation in pharmaceutical development, launched Apisolex in the United States. It is a novel solubility-enhancing excipient for use in parenteral drug products. This technology overcomes solubility hurdles that cannot be resolved by existing excipients or manufacturing techniques.

Similarly, in November 2021, Roquette launched its ready-to-use, pharmaceutical-grade solution for vegetarian soft gel capsule formulation, LYCAGEL Premix. It was developed based on Roquette's market-first pea starch technology called lycagel. The new soft gel blend provides manufacturers with an easy-to-use and convenient solution that ensures fast and reproducible scale-up for nutraceutical and pharmaceutical applications. Such product launches bring more innovative products to the market, which fuels the growth of the market.

Thus, the factors above are anticipated to bolster the market's growth in the North American region.

Pharmaceutical Excipients Market - Growth Rate by Region

Pharmaceutical Excipients Industry Overview

The pharmaceutical excipients market is fragmented in nature. Also, the key market players are involved in various strategic activities such as product launches, collaborations, and agreements to increase their presence and product availability across the globe. Some of the market players are BASF SE, Croda International PLC, DuPont, Evonik Industries AG, Innophos, Kerry, Roquette Frères, and others.

Pharmaceutical Excipients Market Leaders

  1. Lubrizol Corporation

  2. Archer Daniels Midland Company

  3. DuPont

  4. BASF

  5. Evonik Industries AG (RAG-Stiftung)

*Disclaimer: Major Players sorted in no particular order

exp.png
bookmark Need More Details on Market Players and Competitors?
Download PDF

Pharmaceutical Excipients Market News

  • October 2023: Clariant, a sustainability-focused specialty chemicals company, launched its portfolio of high-performing pharmaceutical ingredient solutions to support the evolution of safe and effective medicines. Also, Clariant Health Care expanded its range of functional excipients to solve active pharmaceutical ingredient (API) delivery & bioavailability challenges.
  • September 2023: Roquette, a company focused on plant-based ingredients and a provider of pharmaceutical and nutraceutical excipients, launched three new excipient grades to its portfolio of solutions for moisture-sensitive active pharmaceutical and nutraceutical ingredients.

Pharmaceutical Excipients Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Demand for Functionality Excipients

      2. 4.2.2 Recent Patents Expiries Driving the Demand for Pharmaceutical Excipients

      3. 4.2.3 Rapid Advancements in Nanotechnology

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Proper Approval Process

      2. 4.3.2 Adverse Reactions of Excipients and Contamination in Formulations

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 5.1 By Product

      1. 5.1.1 Inorganic Chemicals

      2. 5.1.2 Organic Chemicals

    2. 5.2 By Functionality

      1. 5.2.1 Fillers and Diluents

      2. 5.2.2 Binders

      3. 5.2.3 Suspension and Viscosity Agents

      4. 5.2.4 Coatings

      5. 5.2.5 Flavoring Agents

      6. 5.2.6 Disintegrants

      7. 5.2.7 Colorants

      8. 5.2.8 Preservatives

      9. 5.2.9 Other Functionalities

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Air Liquide group

      2. 6.1.2 Archer Daniels Midland Company

      3. 6.1.3 Ashland

      4. 6.1.4 Associated British Foods PLC

      5. 6.1.5 BASF SE

      6. 6.1.6 Croda International PLC

      7. 6.1.7 DuPont

      8. 6.1.8 Evonik Industries AG (RAG-Stiftung)

      9. 6.1.9 Innophos

      10. 6.1.10 Kerry

      11. 6.1.11 Roquette Frères

      12. 6.1.12 The Lubrizol Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Pharmaceutical Excipients Industry Segmentation

As per the scope of the report, pharmaceutical excipients are the pharmacologically inactive substances in the formulation that aid in manufacturing the finished pharmaceutical product. They also help transport the active pharmaceutical substance to the site of action in the body. The pharmaceutical excipients market is segmented by product (inorganic chemicals and organic chemicals), functionality (fillers and diluents, binders, suspension, and viscosity agents, coatings, flavoring agents, disintegrants, colorants, preservatives, and other functionalities), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.

By Product
Inorganic Chemicals
Organic Chemicals
By Functionality
Fillers and Diluents
Binders
Suspension and Viscosity Agents
Coatings
Flavoring Agents
Disintegrants
Colorants
Preservatives
Other Functionalities
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
customize-icon Need A Different Region Or Segment?
Customize Now

Pharmaceutical Excipients Market Research FAQs

The Pharmaceutical Excipients Market size is expected to reach USD 9.94 billion in 2024 and grow at a CAGR of 7.93% to reach USD 14.56 billion by 2029.

In 2024, the Pharmaceutical Excipients Market size is expected to reach USD 9.94 billion.

Lubrizol Corporation, Archer Daniels Midland Company, DuPont, BASF and Evonik Industries AG (RAG-Stiftung) are the major companies operating in the Pharmaceutical Excipients Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Pharmaceutical Excipients Market.

In 2023, the Pharmaceutical Excipients Market size was estimated at USD 9.21 billion. The report covers the Pharmaceutical Excipients Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Pharmaceutical Excipients Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Pharmaceutical Excipient Industry Report

Statistics for the 2024 Pharmaceutical Excipients market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Pharmaceutical Excipients analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Pharmaceutical Excipients Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)